Florent Hubé

1.5k total citations
31 papers, 1.2k citations indexed

About

Florent Hubé is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Florent Hubé has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 16 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Florent Hubé's work include RNA Research and Splicing (14 papers), Cancer-related molecular mechanisms research (12 papers) and RNA modifications and cancer (11 papers). Florent Hubé is often cited by papers focused on RNA Research and Splicing (14 papers), Cancer-related molecular mechanisms research (12 papers) and RNA modifications and cancer (11 papers). Florent Hubé collaborates with scholars based in France, Canada and Australia. Florent Hubé's co-authors include Claire Francastel, Guillaume Velasco, Etienne Leygue, Damien Ulveling, Mohammad K. Hamedani, Sophie Iochmann, Pascale Reverdiau, Shilpa Chooniedass‐Kothari, Yves Gruel and Haniaa Bouzinba-Ségard and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Florent Hubé

31 papers receiving 1.2k citations

Peers

Florent Hubé
Philip Olsen United States
Xinjun Ji United States
Bum-Kyu Lee United States
Vera Huang United States
Joel E. Straughen United States
Philip Olsen United States
Florent Hubé
Citations per year, relative to Florent Hubé Florent Hubé (= 1×) peers Philip Olsen

Countries citing papers authored by Florent Hubé

Since Specialization
Citations

This map shows the geographic impact of Florent Hubé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florent Hubé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florent Hubé more than expected).

Fields of papers citing papers by Florent Hubé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florent Hubé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florent Hubé. The network helps show where Florent Hubé may publish in the future.

Co-authorship network of co-authors of Florent Hubé

This figure shows the co-authorship network connecting the top 25 collaborators of Florent Hubé. A scholar is included among the top collaborators of Florent Hubé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florent Hubé. Florent Hubé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonnet, H, Ekaterina Boyarchuk, Denis Furling, et al.. (2025). Small nucleolar RNAs promote the restoration of muscle differentiation defects in cells from myotonic dystrophy type 1. Nucleic Acids Research. 53(6). 1 indexed citations
2.
Francastel, Claire, et al.. (2022). A Tool to Design Bridging Oligos Used to Detect Pseudouridylation Sites on RNA after CMC Treatment. Non-Coding RNA. 8(5). 63–63. 1 indexed citations
3.
Francastel, Claire, et al.. (2021). Systematic Identification and Functional Validation of New snoRNAs in Human Muscle Progenitors. Non-Coding RNA. 7(3). 56–56. 1 indexed citations
4.
Hubé, Florent & Claire Francastel. (2018). Coding and Non-coding RNAs, the Frontier Has Never Been So Blurred. Frontiers in Genetics. 9. 140–140. 40 indexed citations
5.
Léotoing, Laurent, Fanny Chéreau, Silvère Baron, et al.. (2011). A20-binding Inhibitor of Nuclear Factor-κB (NF-κB)-2 (ABIN-2) Is an Activator of Inhibitor of NF-κB (IκB) Kinase α (IKKα)-mediated NF-κB Transcriptional Activity. Journal of Biological Chemistry. 286(37). 32277–32288. 27 indexed citations
6.
Ulveling, Damien, Claire Francastel, & Florent Hubé. (2011). Identification of potentially new bifunctional RNA based on genome-wide data-mining of alternative splicing events. Biochimie. 93(11). 2024–2027. 21 indexed citations
7.
Hubé, Florent, Guillaume Velasco, Jérôme Rollin, Denis Furling, & Claire Francastel. (2010). Steroid receptor RNA activator protein binds to and counteracts SRA RNA-mediated activation of MyoD and muscle differentiation. Nucleic Acids Research. 39(2). 513–525. 117 indexed citations
8.
Velasco, Guillaume, Florent Hubé, Jérôme Rollin, et al.. (2010). Dnmt3b recruitment through E2F6 transcriptional repressor mediates germ-line gene silencing in murine somatic tissues. Proceedings of the National Academy of Sciences. 107(20). 9281–9286. 107 indexed citations
9.
Ferri, Federica, Haniaa Bouzinba-Ségard, Guillaume Velasco, Florent Hubé, & Claire Francastel. (2009). Non-coding murine centromeric transcripts associate with and potentiate Aurora B kinase. Nucleic Acids Research. 37(15). 5071–5080. 112 indexed citations
10.
Skliris, G., Florent Hubé, Mark M. Mutawe, et al.. (2008). Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers. Histopathology. 52(3). 355–369. 32 indexed citations
11.
Hubé, Florent, Jimin Guo, Shilpa Chooniedass‐Kothari, et al.. (2006). Alternative Splicing of the First Intron of the Steroid Receptor RNA Activator (SRA) Participates in the Generation of Coding and Noncoding RNA Isoforms in Breast Cancer Cell Lines. DNA and Cell Biology. 25(7). 418–428. 89 indexed citations
12.
Hubé, Florent. (2006). The promoter competition assay (PCA): a new approach to identify motifs involved in the transcriptional activity of reporter genes. Frontiers in bioscience. 11(1). 1577–1577. 2 indexed citations
13.
Iochmann, Sophie, Claire Bléchet, Florent Hubé, et al.. (2005). Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer. British Journal of Cancer. 92(4). 775–783. 64 indexed citations
14.
Hubé, Florent, Pascale Reverdiau, Sophie Iochmann, & Yves Gruel. (2005). Improved PCR Method for Amplification of GC-Rich DNA Sequences. Molecular Biotechnology. 31(1). 81–84. 53 indexed citations
15.
Hubé, Florent, Mark M. Mutawe, Etienne Leygue, & Yvonne Myal. (2004). Human Small Breast Epithelial Mucin: The Promise of a New Breast Tumor Biomarker. DNA and Cell Biology. 23(12). 842–848. 13 indexed citations
16.
Chooniedass‐Kothari, Shilpa, Ethan Emberley, Mohammad K. Hamedani, et al.. (2004). The steroid receptor RNA activator is the first functional RNA encoding a protein. FEBS Letters. 566(1-3). 43–47. 120 indexed citations
17.
Hubé, Florent, et al.. (2003). Porcine CD58: cDNA cloning and molecular dissection of the porcine CD58–human CD2 interface. Biochemical and Biophysical Research Communications. 309(4). 992–998. 10 indexed citations
18.
Hubé, Florent, et al.. (2003). Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line. Thrombosis Research. 109(4). 207–215. 28 indexed citations
19.
Hubé, Florent, et al.. (2003). Transcriptional Silencing of the TFPI-2 Gene by Promoter Hypermethylation in Choriocarcinoma Cells. Biological Chemistry. 384(7). 1029–34. 31 indexed citations
20.
Iochmann, Sophie, et al.. (2002). Demonstration of inducible TFPI-2 mRNA synthesis in BeWo and JEG-3 trophoblast cells using a competitive RT-PCR. Thrombosis Research. 105(3). 217–223. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026